Ebola vaccine, therapeutics, and diagnostics

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Ebolaviruses cause severe hemorrhagic fever with high fatality rates in humans and primates.
• No approved prophylaxis or treatment for Ebola virus disease (EVD) is currently available.
• The recent West Africa EVD outbreak accelerated the development of medical countermeasures.

Purpose of the Study:

• To review research and recent advances in EVD countermeasures.
• To highlight progress in vaccine, therapeutic, and diagnostic development for EVD.

Main Methods:

• Literature review of previous research.
• Analysis of recent advances in EVD countermeasure development.
• Examination of clinical trial progress for vaccine and drug candidates.

Main Results:

• Several unapproved drugs were used during the West Africa outbreak.
• Development of vaccine and drug candidates has been accelerated.
• Progress has been made in various therapeutic and diagnostic strategies.

Conclusions:

• Continued research and development are crucial for effective EVD control.
• Clinical trials are advancing for promising vaccine and therapeutic candidates.
• Integrated strategies involving vaccines, therapeutics, and diagnostics are needed to combat EVD.